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nger Management
ay Save Your Life
ew Insights Into Emotional
recipitants of Ventricular Arrhythmias*
ric J. Rashba, MD, FACC
tony Brook, New York
udden cardiac arrest is a leading cause of mortality,
ccounting for over 400,000 deaths annually in the U.S.
lone (1). Most sudden cardiac arrests are due to ventricular
achycardia or ventricular fibrillation (1). Given the dismal
urvival statistics for out-of-hospital sudden cardiac arrest,
ubstantial efforts have focused on identifying high-risk
ndividuals who may benefit from prophylactic placement of
n implantable cardioverter-defibrillator (ICD). This “pri-
ary prevention” strategy was validated in the landmark
ADIT-II (Multicenter Automatic Defibrillator Implan-
ation Trial II) (2) and SCD-HeFT (Sudden Cardiac Death
n Heart Failure Trial) (3) studies and incorporated into
urrent treatment guidelines (4). In both of these studies,
he major selection criterion for inclusion was left ventric-
lar dysfunction without additional invasive or noninvasive
See page 774
isk stratification. Although prophylactic ICD placement is
ost-effective in comparison to other established cardiovas-
ular therapies (5), the majority of the patients studied in
he SCD-HeFT and MADIT-II trials did not receive
ppropriate therapies for ventricular arrhythmias. Although
t is anticipated that the incidence of appropriate shocks will
ise with longer follow-up, these patients receive no initial
enefit and incur the large upfront costs of prophylactic
CD implantation. In addition, they are exposed to surgical
omplications, inappropriate shocks, and potential failures
f the implanted defibrillation lead or pulse generator (6).
hese considerations have likely contributed to the reluc-
ance of some cardiologists to prescribe prophylactic ICD
mplantation for patients who meet current treatment
uidelines. As a result, there has been great interest in
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.(
From Stony Brook University Medical Center, Stony Brook, New York. Dr.
ashba is the recipient of research grants from Boston Scientific and Medtronic.eveloping accurate noninvasive risk stratification tests that
an reliably identify low-risk SCD-HeFT patients who may
ot require an ICD.
Microvolt T-wave alternans (TWA) measures beat-to-
eat alternation in the amplitude, shape, or timing of the
-wave. T-wave alternans can arise from differences in
ction potential duration in adjacent myocardial regions
spatial dispersion of repolarization) or from alternation in
ction potential duration over time within a given segment
f myocardium (temporal dispersion of repolarization) (7).
n several animal models, stimuli such as ischemia, ventric-
lar extrasystoles, and progressive increases in heart rate
roduced phenomena such as “discordant alternans” and
igher-order T-wave oscillations, which create large spatial
radients of repolarization (8,9). The presence of spatial
ispersion of repolarization favors the occurrence of unidi-
ectional block, re-entrant propagation, and the initiation of
entricular fibrillation (8). These experimental findings
uggested that TWA is mechanistically linked to the patho-
enesis of ventricular fibrillation and sudden cardiac arrest.
ecent clinical studies have also documented that surges of
WA occur immediately before episodes of sustained ven-
ricular tachycardia on Holter monitoring (10) and before
pontaneous ventricular arrhythmias requiring treatment in
CD patients (11).
Most clinical trials of TWA have been conducted using
he commercially available spectral method. In numerous
tudies conducted using this methodology, TWA has been
ssociated with an increased risk of spontaneous and induc-
ble ventricular arrhythmias (12–15). The major focus of
ecent clinical investigations of TWA has been to assess the
egative predictive value (NPV) of the test in patients who
re currently candidates for primary prevention ICDs. If the
PV is sufficiently high (i.e., 95%), ICD implantation
ould be safely deferred in patients with a negative TWA
est. Initial results were favorable in some (14,15) but not all
16,17) studies. Potential reasons for this discrepancy in-
lude differing risk profiles of the populations studied,
hich directly influences the NPV, and lack of standard-
zation of ICD programming, which can influence end
oint event detection. These limitations were overcome in 2
ecent large TWA trials that required standardized ICD
rogramming: MASTER (Microvolt T-Wave Alternans
esting for Risk Stratification of Post-Myocardial Infarc-
ion Patients) trial (18) and the SCD-HeFT TWA sub-
tudy (19). Remarkably, TWA did not predict arrhythmic
vents in either trial. Although it is well recognized that
entricular arrhythmias detected by ICDs can overestimate
he risk of sudden cardiac arrest, as some of these arrhyth-
ias may have abated spontaneously (20), these data have
ubstantially dampened enthusiasm for using TWA as a
creening test to withhold ICDs from patients who meet
urrent primary prevention criteria. The high rate of “inde-
erminate” TWA tests in the SCD-HeFT TWA substudy
41%) is also of interest (19). The spectral method of TWA
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Emotional Precipitants of Ventricular Arrhythmias March 3, 2009:779–81easurement requires elevation of the heart rate to 105
eats/min or greater using treadmill exercise. Indeterminate
ests occur when patients are deconditioned or when fre-
uent ventricular ectopy is present; noisy recordings that
eflect technical rather than patient factors are no longer
onsidered indeterminate (21). Recent evidence indicates
hat indeterminate TWA tests carry an adverse prognosis
imilar to that of a positive TWA test, which has led to the
lassification of TWA results as “negative” and “non-
egative” (21). Many of the favorable reports of TWA had
ery low rates of indeterminate tests (10% to 20%)
14,15), which likely reflect selection of lower-risk patients
ho are able to complete the exercise protocol and who lack
mbient ventricular ectopy. If the SCD-HeFT results truly
epresent the “real world” of spectral TWA measurement,
ther methodologies to measure TWA may be needed if
WA is to be useful clinically. The available data regarding
hysiological influences on TWA provide important guid-
nce for future research directions in this area.
T-wave alternans is critically dependent on heart rate
22). Early studies of TWA used atrial pacing during
lectrophysiological studies to elevate the heart rate (12).
ubsequently, protocols were developed using bicycle er-
ometer and treadmill exercise that allowed TWA testing to
e performed noninvasively (13,14). Exercise TWA testing
as greater prognostic value than TWA testing using pacing
23). The most likely explanation for this finding is that the
ympathetic activation and vagal withdrawal induced by
hysical exercise more closely approximates the autonomic
ilieu that provokes spontaneous ventricular arrhythmias.
imilarly, acute beta blockade markedly reduces the magni-
ude of TWA and the prevalence of positive TWA tests
ndependent of heart rate effects (24). Adrenergic activation
an be induced by anger and the strong emotions that may
e experienced after natural disasters. Sudden cardiac arrest
ncreases after earthquakes (25), and ICD patients experi-
nced a greater incidence of appropriate ICD therapies
ollowing September 11, 2001 (26). Other investigators
ave documented that an anger-like behavioral state induces
WA in canines (27), and mental stress (anger recall and
ental arithmetic) can elicit TWA in humans (28,29).
In this issue of the Journal, Lampert et al. (30) present
ew data regarding the prognostic value of anger-induced
WA in patients with ICDs. They studied 62 patients with
CDs during a mental stress protocol using ambulatory
lectrocardiograms. T-wave alternans was measured using 2
ime-domain techniques: the intrabeat average and modi-
ed moving average analyses. Time-domain techniques
ffer the potential advantage of expanding the pool of
atients eligible for risk stratification if sufficient informa-
ion can be obtained from ambulatory electrocardiogram
ecordings without exercise testing. The investigators pro-
ide the first evidence that patients with higher levels of
nger-induced TWA during provocative testing are at
reater risk for ventricular arrhythmias detected by ICDs
uring follow-up. Important limitations of this study in-lude the small sample size, the highly selected nature of
his small cohort enrolled over nearly 4 years, the low event
ate, and the impact of lack of standardization of ICD
rogramming on the primary end point. Although time-
omain techniques offer the potential advantage of greater
pplicability to larger numbers of patients who need risk
tratification, several issues must still be resolved including
he lack of validated cut points, uncertainty regarding the
eed for exercise testing to detect sufficient levels of TWA,
nd the comparability of time-domain TWA results to the
pectral method. Future studies should investigate whether
rovocative testing for anger-induced TWA improves the
PV of TWA testing conducted using the spectral and
ime-domain methods and whether this new methodology
ould facilitate the identification of susceptible patients with
ess severe left ventricular dysfunction, who comprise the
reatest proportion of those who experience sudden cardiac
rrest events (31).
eprint requests and correspondence: Dr. Eric J. Rashba,
irector, Electrophysiology Laboratories, Stony Brook University
chool of Medicine, Health Sciences Center T16-080, 100 Nicolls
oad, Stony Brook, New York 11794. E-mail: eric.rashba@
tonybrook.edu.
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